ELV
Elevance Health, Inc.
Cash flow statement
| USDLine, in USD | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 7.6B | 4.3B | 5.8B | 8.1B | 8.4B | 8.4B | 10.7B | 6.1B | 3.8B | 4.2B | 3.3B | 4.2B | 3.4B | 3.1B | 2.7B | 3.4B | 1.4B | 3.0B | 2.5B | 4.3B |
| 1.08B | 1.12B | 1.26B | 1.30B | 1.15B | 1.09B | 1.02B | 1.08B | 1.21B | 0.79B | 0.58B | 0.64B | 0.71B | 0.65B | 0.54B | 0.52B | 0.45B | 0.38B | 0.35B | 0.32B | |
| Free cash flow | 6.51B | 3.17B | 4.55B | 6.77B | 7.25B | 7.28B | 9.67B | 4.98B | 2.62B | 3.39B | 2.69B | 3.57B | 2.65B | 2.41B | 2.20B | 2.85B | 0.97B | 2.66B | 2.19B | 4.02B |
| Depreciation and amortization | 1.49B | 1.55B | 1.39B | 1.75B | 1.68B | 1.30B | 1.15B | 1.13B | 1.13B | 0.89B | 0.91B | 0.91B | 0.85B | 0.91B | 0.74B | 0.64B | 0.60B | 0.55B | 0.57B | 0.59B |
| Stock-based compensation | 240M | 276M | 191M | 289M | 264M | 255M | 283M | 294M | 226M | 170M | 165M | 148M | 169M | 146M | 147M | 135M | 136M | 154M | 156M | 177M |
| Buybacks | 2.16B | 2.61B | 2.90B | 2.68B | 2.32B | 1.90B | 2.70B | 1.70B | 1.69B | 2.00B | 0 | 1.52B | 3.00B | 1.62B | 2.50B | 3.04B | 4.36B | 2.64B | 3.28B | 6.15B |
| Dividends paid | 1.50B | 1.53B | 1.51B | 1.40B | 1.23B | 1.10B | 0.95B | 0.82B | 0.78B | 0.71B | 0.68B | 0.66B | 0.48B | 0.45B | 0.37B | 0.36B | 0 | — | — | — |
| Dividends per share | 6.87 | — | — | 5.92 | 5.12 | 4.52 | 3.80 | 3.20 | 3.00 | 2.70 | 2.60 | 2.50 | 1.75 | 1.50 | 1.15 | 1.00 | 0.00 | — | — | — |
| Free cash flow margin | 3.2% | 1.6% | 2.6% | 3.9% | 4.6% | 5.2% | 7.9% | 4.8% | 2.8% | 3.8% | 3.2% | 4.5% | 3.6% | 3.4% | 3.6% | 4.7% | 1.6% | 4.1% | 3.6% | 6.6% |